BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Furuyama W, Shifflett K, Feldmann H, Marzi A. The Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathway. PLoS Pathog 2021;17:e1009937. [PMID: 34529738 DOI: 10.1371/journal.ppat.1009937] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang J, Wang B, Gao X, Peng C, Shan C, Johnson SF, Schwartz RC, Zheng YH. RNF185 regulates proteostasis in Ebolavirus infection by crosstalk between the calnexin cycle, ERAD, and reticulophagy. Nat Commun 2022;13:6007. [PMID: 36224200 DOI: 10.1038/s41467-022-33805-9] [Reference Citation Analysis]
2 Dhanya CR, Shailaja A, Mary AS, Kandiyil SP, Savithri A, Lathakumari VS, Veettil JT, Vandanamthadathil JJ, Madhavan M. RNA Viruses, Pregnancy and Vaccination: Emerging Lessons from COVID-19 and Ebola Virus Disease. Pathogens 2022;11:800. [PMID: 35890044 DOI: 10.3390/pathogens11070800] [Reference Citation Analysis]
3 Koch-heier J, Schönsiegel A, Waidele LM, Volk J, Füll Y, Wallasch C, Canisius S, Burnet M, Planz O. Pharmacokinetics, Pharmacodynamics and Antiviral Efficacy of the MEK Inhibitor Zapnometinib in Animal Models and in Humans. Front Pharmacol 2022;13:893635. [DOI: 10.3389/fphar.2022.893635] [Reference Citation Analysis]